Umeå University's logo

umu.sePublications
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Enhancing existing tumour biobanks in European prospective cohort studies
Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Cancer Epidemiology Program, Dana-Farber Harvard Cancer Center, MA, Boston, United States; Division of Integrative Cancer Research, National Cancer Center Research Institute, Tsukiji, Tokyo, Japan.
Umeå University, Faculty of Medicine, Department of Diagnostics and Intervention. Umeå University, Faculty of Medicine, Wallenberg Centre for Molecular Medicine at Umeå University (WCMM).ORCID iD: 0000-0002-9692-101X
Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Cancer Epidemiology Program, Dana-Farber Harvard Cancer Center, MA, Boston, United States; Discovery Science, American Cancer Society, GA, Atlanta, United States.
Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, MA, Boston, United States; Department of Epidemiology, Harvard T.H. Chan School of Public Health, MA, Boston, United States; Cancer Epidemiology Program, Dana-Farber Harvard Cancer Center, MA, Boston, United States; Broad Institute of MIT and Harvard, MA, Cambridge, United States; Cancer Immunology Program, Dana-Farber Harvard Cancer Center, MA, Boston, United States; Division of Nutrition, Harvard Medical School, MA, Boston, United States; Institute of Science Tokyo, Tokyo, Japan.
2025 (English)In: The Lancet Regional Health: Europe, E-ISSN 2666-7762, Vol. 53, article id 101293Article in journal, Editorial material (Refereed) Published
Place, publisher, year, edition, pages
Elsevier, 2025. Vol. 53, article id 101293
National Category
Medical Genetics and Genomics Basic Cancer Research Medical Bioinformatics and Systems Biology
Identifiers
URN: urn:nbn:se:umu:diva-238448DOI: 10.1016/j.lanepe.2025.101293ISI: 001466389800001PubMedID: 40255932Scopus ID: 2-s2.0-105001803340OAI: oai:DiVA.org:umu-238448DiVA, id: diva2:1957342
Available from: 2025-05-09 Created: 2025-05-09 Last updated: 2025-05-09Bibliographically approved

Open Access in DiVA

fulltext(517 kB)8 downloads
File information
File name FULLTEXT01.pdfFile size 517 kBChecksum SHA-512
541345b2b1512c743afcac8bfe59665214992ca5637af7842621cde750a4c330bf249f6b2a73e5061a65f78c7c05ab078947d0d80247cc45d826b2a66098774a
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Authority records

van Guelpen, Bethany

Search in DiVA

By author/editor
van Guelpen, Bethany
By organisation
Department of Diagnostics and InterventionWallenberg Centre for Molecular Medicine at Umeå University (WCMM)
In the same journal
The Lancet Regional Health: Europe
Medical Genetics and GenomicsBasic Cancer ResearchMedical Bioinformatics and Systems Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 8 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 137 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf